What We're Reading: Page 73
Industry reads hand-picked by our editors
Oct 16, 2023
-
Bloomberg
Sickle Cell Gene Therapy Will Test How US Pays for Million-Dollar Cures
-
Axios
Medicare lifts limit on brain scans for Alzheimer’s patients
-
The New York Times
Wearables Track Parkinson’s Better Than Human Observation, Study Finds
-
Boston Business Journal
For biotech entrepreneur Greg Verdine, opportunity just kept knocking
Oct 13, 2023
-
Fierce Biotech
IRA drives Relay to pause plans to win approval in rare cancer
-
Axios
Flagship Pioneering’s Berenson says bad industry outlook will continue
-
Science
Co-developer of Cassava’s potential Alzheimer’s drug cited for ‘egregious misconduct’
-
Bloomberg
JPMorgan Health-Care Dealmaker Robbie Huffines to Retire
Oct 12, 2023
Oct 11, 2023
Oct 10, 2023
Oct 09, 2023
Oct 06, 2023
-
Bloomberg
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
-
The Wall Street Journal
After Shunning Scientist, University of Pennsylvania Celebrates Her Nobel Prize
-
Reuters
GSK raises $1.1 billion from Haleon stake sale
-
Fierce Biotech
Why is the medical device lobby suing the Library of Congress?